ReviewFrontiers in plant science2025
Exploiting microalgal diversity for sterol production.
Review in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antioxidant Compounds in Microalgae and Cyanobacteria: A Sustainable Source of Bioactive Molecules.Marine drugs · 2026Review
- Biogenic Synthesis, Structural Characterization, and Biological Evaluation of Nanoparticles Derived fromNanomaterials (Basel, Switzerland) · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sterols are essential for eukaryotic cell membrane integrity and fluidity, and they demonstrate valuable pharmaceutical and nutraceutical benefits, including anti-inflammatory, antioxidant, anti-cancer, and cholesterol-lowering properties. Traditionally, animal, plant, and microbial fermentation sterols face sustainability, economic, and ethical challenges. Microalgae have emerged as a promising alternative due to their biochemical diversity, rapid growth, and controlled cultivation capabilities. This review explores microalgae's potential for sterol production, highlighting their advantages, including sustainability and sterol profile diversity, while addressing key challenges of low sterol yields, species-dependent variations, and industrial scalability. We discuss how recent advancements in metabolic engineering, cultivation technologies, and process optimization could enhance sterol production. By integrating innovative biotechnological strategies, microalgae hold the potential to become a viable and sustainable sterol source for pharmaceutical, nutraceutical, and industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.